. 2017 Aug 24;8(46):80820–80825. doi: 10.18632/oncotarget.20542

Table 1. Comparison of thyroid function status among initially diagnosed breast cancer patients, benign breast disease patients and breast cancer during chemotherapy ( $\bar{x} \pm s$ ).

Groups	case	Age	T3(ng/ml)	T4(ug/dl)	FT3(pg/ml)	FT4(ng/dl)	TSH(uIU/ml)
Initially diagnosed breast cancer	726	51.03±10.98	1.05±0.22	7.68±1.51	3.07±0.50	0.88±0.20	3.23±4.59
benign breast diseases	336	44.5±12.23^*	1.04±0.22	7.29±1.52^**	3.07±0.43	0.86±0.14	3.60±6.74
during chemotherapy	153	49.03±8.50^*	1.04±0.24	7.08±1.69^**	2.87±0.48^**	0.83±0.15^*	2.77±3.18

^*p<0.05 ^** p<0.001 vs. initially diagnosed breast cancer.

Table 1. Comparison of thyroid function status among initially diagnosed breast cancer patients, benign breast disease patients and breast cancer during chemotherapy (x¯±s).